Philip Morris International Inc. (PM) financials
NYSE · Consumer Defensive · Tobacco · 84,900 employees · CEO Jacek Olczak
- Price
- $208.79 +0.14%
- Market cap
- $325B
- Enterprise value
- $366B
- Last report
- Q3 '26 filed 2026-10-23
- Next report
- 2027-02-05 EPS est. $1.85
Valuation & key figures
- Market cap
- $325B EV $366B
- Revenue
- $43.1B Trailing 12 months
- Revenue growth
- +7% FY2026 consensus
- Profit margin
- 24.8% Net income / revenue, TTM
- P/E
- 30.5× Forward 25.0× (FY2026)
- P/S
- 7.5× Price / sales, TTM
- EV / EBITDA
- 19.5× TTM
- Free cash flow
- $13.6B Trailing 12 months
- Net income
- $10.7B Trailing 12 months
- Revenue estimate
- $43.5B FY2026 consensus
- Earnings
- 2027-02-05 Revenue est. $10.9B
- Dividend
- $6.01 Per share, last 12 months
Key takeaways
Computed from the reported numbers - every statement carries the figure it rests on.
- Last report (2026-10-21): revenue beat by 1.1%, EPS beat by 2.6%Revenue $11.4B vs $11.3B expected (+1.1%); EPS $2.36 vs $2.30 (+2.6%).
- Revenue growth slowing: 5.5% year on yearQ3 '26 revenue $11.4B, against an average of 8.9% over the four quarters before.
- Operating margin 38.6% (TTM), +1.6 pp on a year agoOperating income grew 12.4% while revenue grew 7.9%.
- 10.6% of pre-tax profit is eaten by non-operating lossesPre-tax income $15.1B vs operating income $16.7B (TTM). Losses on equity stakes and other one-off items cut net income and EPS - operating income is the cleaner measure of the business.
- Capex 3.6% of revenue (a year ago 3.5%)$1.56B invested in the last 4 quarters (+11.1% on a year earlier). Free cash flow $13.6B = 126.9% of net income.
- Returned $9.2B to shareholders = 67.7% of free cash flowBuybacks $0 (a year earlier $0), dividends $9.2B, stock-based pay $0 (TTM).
- Diluted share count up 0.3% in a year1.56B diluted shares in Q3 '26, 1.56B a year earlier.
- Net debt $40.9BCash + short-term investments $6.68B, debt incl. leases $47.6B; a year ago net debt $46B.
- Europe Segment: revenue +11.0%, margin 41.5% (was 42.2%)Fastest-growing reported segment in Q4 '25: operating income $1.91B on revenue $4.6B (from the segment note of the filing).
Last quarter: Q3 '26
Quarter ended 2026-09-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.
Quarter vs a year ago
| Q3 '26 | Year ago | Change | |
|---|---|---|---|
| Revenue | $11.4B | $10.8B | +5.5% |
| Gross margin | 68.7% | 67.8% | +0.8 pp |
| Operating income | $4.87B | $4.26B | +14.1% |
| Operating margin | 42.5% | 39.3% | +3.2 pp |
| Net income | $3.31B | $3.48B | -4.7% |
| Diluted EPS | $2.12 | $2.23 | -4.9% |
| Operating cash flow | $5.35B | $4.46B | +19.9% |
| Capex | $382M | $365M | +4.7% |
| Free cash flow | $4.97B | $4.1B | +21.3% |
| R&D | $0 | $0 | – |
| Stock-based compensation | $0 | $0 | – |
Reported vs consensus
2026-10-21| Actual | Consensus | vs consensus | |
|---|---|---|---|
| Revenue | $11.4B | $11.3B | +1.1% |
| EPS (as estimated) | $2.36 | $2.30 | +2.6% |
From the report of 2026-10-21 for Q3 '26: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.
EPS vs consensus
last 8 reportsRevenue
Where the money comes from - by business line and by region, quarter by quarter.
Revenue, operating income and growth
quarterlyRevenue by business line
stacked, quarterly| Segment | Q3 '26 | y/y | Share | TTM | TTM y/y | 12 quarters |
|---|---|---|---|---|---|---|
| Combustible Products | $6.81B | +6.4% | 59.6% | $25.1B | +6.5% | |
| Reduced-Risk Products | $4.63B | +4.0% | 40.4% | $18B | +9.8% |
Revenue by region
share of total| Segment | Q3 '26 | y/y | Share | TTM | TTM y/y | 12 quarters |
|---|---|---|---|---|---|---|
| EA, AU & PMI GTR Segment | $4.86B | – | 35.2% | – | – | |
| European Union | $4.6B | +13.4% | 33.3% | $17.1B | +11.4% | |
| SSEA, CIS & MEA Segment | $3.11B | +8.4% | 22.5% | $12.1B | +7.0% | |
| East Asia And Australia | – | – | – | – | – | |
| Americas Segment | $1.23B | -2.5% | 8.9% | $4.85B | +7.1% |
Segment profits
Operating income per reported segment, read from the segment note of each 10-Q / 10-K (the profit split most data feeds leave out).
Segments in Q4 '25
| Segment | Revenue | y/y | Operating income | y/y | Margin | Margin a year ago | TTM operating income |
|---|---|---|---|---|---|---|---|
| Europe Segment | $4.6B | +11.0% | $1.91B | +9.1% | 41.5% | 42.2% | $7.17B |
| SSEACISMEA Segment | $3.11B | +8.4% | $941M | +16.7% | 30.3% | 28.1% | $4.1B |
| EAAUPMIDF Segment | – | – | – | – | – | – | – |
| EAAUPMIGTR Segment | $1.43B | -0.6% | $514M | -10.5% | 36.1% | 40.0% | $3.13B |
| Americas Segment | $1.23B | -2.5% | $8M | -93.8% | 0.7% | 10.2% | $505M |
| Wellness And Healthcare Segment | – | – | – | – | – | – | – |
Operating income by segment
quarterlySegment operating margin
quarterlyFourth quarters are derived: the 10-K reports the full year, minus the three quarters of the 10-Qs.
Margins & cost structure
How much of each unit of revenue is left at each level - and where the costs go.
Margins
quarterlyCosts as % of revenue
quarterlyCash flow & capital allocation
Cash generated, what it is spent on, and what reaches shareholders.
Operating cash flow, capex, free cash flow
quarterlyUses of cash vs operating cash flow
fiscal yearsLast 4 quarters
cash flow statement- Operating cash flow
- $15.2B
- Capex
- -$1.56B
- Buybacks
- $0
- Dividends
- -$9.2B
- Acquisitions
- $25M
- Net debt issued
- -$2.04B
- Stock-based compensation
- $0
- Free cash flow
- $13.6B
- Returned to shareholders / FCF
- 67.7%
Share count and EPS
quarterly, dilutedBalance sheet
Liquidity, investments and debt at each quarter end.
Cash, investments and debt
quarter endsValuation & returns
Today's multiples against the company's own last five fiscal years; analyst targets and ratings.
Multiples and returns
TTM vs 5 fiscal years| Now | 5y average | Where today sits in the 5-year range | |
|---|---|---|---|
| P/E (TTM) | 30.5× | 20.2× | 16.3× – 26.6× |
| EV / EBITDA | 19.5× | 14.3× | 12.3× – 15.7× |
| EV / Sales | 8.5× | 6.1× | 5.4× – 7.2× |
| Price / FCF | 23.9× | 17.7× | 13.2× – 23.4× |
| Price / Book | -41.1× | – | – |
| FCF yield | 4.2% | 5.8% | 4.3% – 7.6% |
| Return on invested capital | 27.5% | 26.9% | 19.8% – 40.6% |
| Return on equity | -119.7% | -86.8% | -113.5% – -59.9% |
Analysts
Consensus target $214.57 (+2.8%)
range $201.00 – $225.00 · rating Buy
Outlook
Analyst consensus for the coming fiscal years and what it implies at today's price.
Consensus estimates
| Fiscal year | Revenue | Growth | EPS | Growth | P/E at today's price | Analysts (EPS) |
|---|---|---|---|---|---|---|
| FY2026 | $43.5B | +7.1% | $8.35 | +15.0% | 25.0× | 8 |
| FY2027 | $45.6B | +4.7% | $9.07 | +8.7% | 23.0× | 8 |
| FY2028 | $48.2B | +5.6% | $9.86 | +8.7% | 21.2× | 3 |
| FY2029 | $49.7B | +3.2% | $10.56 | +7.0% | 19.8× | 1 |
| FY2030 | $52.3B | +5.2% | $11.83 | +12.1% | 17.6× | 1 |
Financial statements
Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.
Every reported line
All 311 figures Philip Morris International Inc. tagged in its recent 10-Q / 10-K filings, with the official SEC label and definition - including the notes (leases, taxes, buybacks, employees, ...).
| Line (SEC label) | Latest quarter | Year ago | y/y | Latest FY | Prior FY | y/y |
|---|---|---|---|---|---|---|
| Accounts Payable, Current | $4.04B | $3.98B | +1.5% | $4.41B | $3.95B | +11.5% |
| Accounts Receivable, after Allowance for Credit Loss, Current | $5.16B | $4.8B | +7.5% | $4.57B | $3.79B | +20.7% |
| Accounts Receivable, Allowance for Credit Loss, Current | $36M | $25M | +44.0% | $23M | $47M | -51.1% |
| Accounts Receivable, Allowance for Credit Loss, Noncurrent | $11M | $12M | -8.3% | $12M | $26M | -53.8% |
| Accounts Receivable, Sale | $3.1B | $3B | +3.3% | $11.7B | $11.9B | -1.7% |
| Accrued Income Taxes, Current | $1.36B | $835M | +63.0% | $1.26B | $1.26B | -0.2% |
| Accrued Marketing Costs, Current | $1.47B | $1.41B | +4.6% | $1.35B | $1.02B | +33.4% |
| Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax | $1.41B2025-12-31 | $2.46B | -42.9% | $1.41B | $2.46B | -42.9% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | -$11.9B | -$13.3B | +10.9% | -$12.3B | -$11.3B | -8.7% |
| Additional Paid in Capital, Common Stock | $2.53B | $2.4B | +5.2% | $2.45B | $2.34B | +5.1% |
| Advertising Expense | – | – | – | $1.36B | $1.07B | +26.8% |
| Allowance for Doubtful Other Receivables, Current | $24M | $23M | +4.3% | $24M | $22M | +9.1% |
| Amortization of Intangible Assets | $247M | $250M | -1.2% | $1B | $835M | +20.1% |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 0 | 0 | – | 0 | 0 | – |
| Assets | $66.7B | $67.1B | -0.5% | $69.2B | $61.8B | +12.0% |
| Assets, Current | $25.8B | $22.7B | +13.8% | $24.4B | $20.2B | +20.8% |
| Buildings and Improvements, Gross | $5.05B2025-12-31 | $4.39B | +15.0% | $5.05B | $4.39B | +15.0% |
| Cash Acquired from Acquisition | $02025-12-31 | -$1M | +100.0% | $0 | $43M | -100.0% |
| Cash and Cash Equivalents, at Carrying Value | $6.68B | $4.04B | +65.5% | $4.87B | $4.22B | +15.6% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $6.71B | $4.06B | +65.1% | $4.89B | $4.25B | +15.0% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $682M | -$115M | +693.0% | $638M | $1.11B | -42.4% |
| Common Stock, Dividends, Per Share, Declared | $1.60 | $1.47 | +8.8% | $5.64 | $5.30 | +6.4% |
| Common Stock, Shares Authorized | 6B2025-12-31 | 6B | 0.0% | 6B | 6B | 0.0% |
| Common Stock, Shares, Issued | 2.11B | 2.11B | 0.0% | 2.11B | 2.11B | 0.0% |
| Common Stock, Value, Issued | $0 | $0 | – | $0 | $0 | – |
| Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest | $171M | $106M | +61.3% | $497M | $345M | +44.1% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $3.1B | $3.31B | -6.4% | $10.4B | $7.56B | +37.2% |
| Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | $3.27B | $3.42B | -4.3% | $10.9B | $7.9B | +37.5% |
| Construction in Progress, Gross | $1.47B2025-12-31 | $1.08B | +36.1% | $1.47B | $1.08B | +36.1% |
| Cost of Goods and Services Sold | $3.58B | $3.48B | +2.9% | $13.4B | $13.3B | +0.3% |
| Costs and Expenses, Related Party | $59M | $45M | +31.1% | $210M | $101M | +107.9% |
| Current Federal Tax Expense (Benefit) | – | – | – | $371M | $465M | -20.2% |
| Current Foreign Tax Expense (Benefit) | – | – | – | $3.18B | $2.67B | +19.3% |
| Current Income Tax Expense (Benefit) | – | – | – | $3.58B | – | – |
| Current State and Local Tax Expense (Benefit) | – | – | – | $31M | – | – |
| Debt Instrument, Unamortized Discount | $338M2025-12-31 | $431M | -21.6% | $338M | $431M | -21.6% |
| Deferred Federal Income Tax Expense (Benefit) | – | – | – | -$817M | -$81M | -908.6% |
| Deferred Foreign Income Tax Expense (Benefit) | – | – | – | $10M | -$35M | +128.6% |
| Deferred Income Tax Assets, Net | $1.22B | $1.06B | +15.8% | $1.25B | $940M | +32.7% |
| Deferred Income Tax Expense (Benefit) | -$25M | -$159M | +84.3% | -$847M | -$123M | -588.6% |
| Deferred Income Tax Liabilities, Net | $1.98B | $2B | -0.8% | $2.07B | $2.52B | -18.0% |
| Deferred State and Local Income Tax Expense (Benefit) | – | – | – | -$40M | – | – |
| Deferred Tax Assets, Gross | $3.8B2025-12-31 | $2.33B | +63.5% | $3.8B | $2.33B | +63.5% |
| Deferred Tax Assets, Inventory | $47M2025-12-31 | $40M | +17.5% | $47M | $40M | +17.5% |
| Deferred Tax Assets, Net of Valuation Allowance | $2.09B2025-12-31 | $1.2B | +75.1% | $2.09B | $1.2B | +75.1% |
| Deferred Tax Assets, Operating Loss Carryforwards | $1.54B2025-12-31 | $912M | +69.1% | $1.54B | $912M | +69.1% |
| Deferred Tax Assets, Other | $325M2025-12-31 | $62M | +424.2% | $325M | $62M | +424.2% |
| Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Pensions | $189M2025-12-31 | $384M | -50.8% | $189M | $384M | -50.8% |
| Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | $212M2025-12-31 | $213M | -0.5% | $212M | $213M | -0.5% |
| Deferred Tax Assets, Unrealized Currency Losses | $451M2025-12-31 | $0 | – | $451M | $0 | – |
| Deferred Tax Assets, Valuation Allowance | $1.71B2025-12-31 | $1.13B | +51.2% | $1.71B | $1.13B | +51.2% |
| Deferred Tax Liabilities, Gross | $2.91B2025-12-31 | $2.77B | +5.0% | $2.91B | $2.77B | +5.0% |
| Deferred Tax Liabilities, Intangible Assets | $1.94B2025-12-31 | $1.86B | +4.0% | $1.94B | $1.86B | +4.0% |
| Deferred Tax Liabilities, Net | $818M2025-12-31 | $1.58B | -48.1% | $818M | $1.58B | -48.1% |
| Deferred Tax Liabilities, Other | $02025-12-31 | $0 | – | $0 | $0 | – |
| Deferred Tax Liabilities, Property, Plant and Equipment | $165M2025-12-31 | $152M | +8.6% | $165M | $152M | +8.6% |
| Deferred Tax Liabilities, Undistributed Foreign Earnings | $811M2025-12-31 | $495M | +63.8% | $811M | $495M | +63.8% |
| Deferred Tax Liabilities, Unrealized Currency Transaction Gains | $02025-12-31 | $264M | -100.0% | $0 | $264M | -100.0% |
| Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax | -$48M2025-12-31 | -$55M | +12.7% | -$48M | -$55M | +12.7% |
| Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax | -$1.69B2025-12-31 | -$2.97B | +43.2% | -$1.69B | -$2.97B | +43.2% |
Source: SEC companyfacts (XBRL of every 10-Q / 10-K). Cash-flow quarters are derived from the year-to-date figures the 10-Q tags. Segment breakdowns are tagged with dimensions and are shown in the segment section instead.
Sources
Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30
Data as of 2026-11-01